PP174. THE EFFICIENCY OF SUBSTITUTIVE HORMONAL THERAPY OF FEMOSTON BY DYSGENESIS OF GONADS
MALIKOVA RANO MUMINOVNA Samarkand State Med. Inst., the Department of obstetrics and gynecology of the pediatric faculty, Uzbekistan e-mail: niholm@rambler.ru
*Corresponding Author:
page: 125

Abstract

The digenesis of gonads is a rare enough genetic pathology, revealing at 1 on 10-12 thousand live-born children. The principles of treatment of the given pathology are known rather for a long time, but there is no precise circuit substitutive hormonal of therapy at the various forms the digenesis of gonads.

Goal. To value the efficiency of Femoston by the digenesis of gonads.

Materials and methods. We examined 50 female patients in age of 12 – 23 with various forms of digenesis of gonads. We made the complex clinical and laboratory investigation.

Results and conclusions. On cariotype we determined that Swyer’s syndrome – 5 (10 %) – 46,XY; mixed form (45,XO/46,XY) – 1 (2 %), typical form or Shereshevsky-Turner’s syndrome (45,XO) – 7 (14 %), mosaic form (45,XO/46,XX) – 7 (14 %), pure form (46,XX) – 30 (60 %).

Comparison of hormonal parameters of the patients with the digenesis of gonads after traditional cyclic and modified hormonotherapy

Summing up discussion of various kinds of hormonotherapy, it is necessary to emphasize the expressed advantages of purpose patients with the various forms of digenesis of gonads of preparations containing natural female sexual hormones 17? - estradiol as a preparation Femoston. 

 

 

Groups

A kind of medical influence

FSH

LH

Estradiol

Progesterone

mME/ml

pmol/l

nmol/l

I

n = 17

 

Starting

Ethinyl estradiol

58,1 ± 4,3

25,8 ± 2,61

29,82±5,69

12,2 ± 1,25

156,3 ± 9,8

175,3±10,0

1,6 ± 0,12

2,62 ± 0,46

II

n = 10

 

 

Regulon

70,8 ± 3,5

14,8 ± 2,0

 

14,3 ± 0,32

8,8 ± 1,13

 

144,8 ± 12,0

194,9 ± 13,0

 

1,75 ± 0,15

3,02 ± 0,68

 

III

n = 23

 

Femoston

108 ± 10,5

15,9 ± 1,8

 

11,2 ± 0,25

9,3 ±  0,95

 

165 ± 12,8

265,3±14,6

 

2,0 ± 0,22

3,1 ± 0,68

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006